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were subjected to electrophoresis on 3% NuSieve/1% Sea Kern agarose (FMC BioProducts, Rockland, ME) and to Southern blot analysis (ONCOR Sure blot) using a 32 p-labeled probe specific for the HIV-1 gag region (12, 13) .
Necropsy of Infected Animals. At various time points post-infection, heavily sedated rabbits were exsanguinated by cardiac puncture . Spleens were taken under sterile conditions and divided into portions for cell culture and for pathology. Flow cytometry analysis was carried out on spleen cells using antibody reagents for human (Becton Dickinson & Co., Mountain View, CA) and rabbit lymphoid cell populations (14) . Organs were fixed in neutral formalin and sent to a veterinary pathology lab (Maryland Medical Inc., Baltimore, MD) for diagnosis .
Results
Four groups ofexperimental and control rabbits were formed for infections with HIV 1: group 1 consisted of five rabbits infected with HTLV1; group 2 consisted of three rabbits injected with HIV-1-infected A3.01 cells; group 3 consisted of six rabbits seropositive for HTLV1 subsequently injected with HIV-1-infected A3 .01 cells ; and group 4 consisted of two control rabbits given A3 .01 cells not infected with HIV 1.
Serologic Analyses of Infected Rabbits. Within N6 wk all rabbits injected with HIV-1 were seropositive for HIVI. Rabbits seropositive for HTLV1 before injection ofHIV-1 became seropositive sooner and gave stronger responses than those infected with HIV-1 only. No crossreactivity between HTLV1 and HIV-l' sera was observed by ELISA, and sera from control rabbits were negative in both assays . Positive samples were shown by Western Blot analyses to have antibodies directed against various HIV-1 proteins .
Isolation and Characterization of HIV-1fiom Infected Rabbits. Observation ofPBL cultures revealed formation of syncytia in those taken from HIV-1-infected rabbits . Fig .  1 shows PBL from uninfected (A), HIV-1-(B), and HTLV1/HIV1-(C) infected rabbits after 2 wk ofgrowth in IL-2-supplemented medium . As shown in Fig. 2 , RT activity was observed in cell-free culture (and A3 .01 coculture) supernatants ofPBL obtained from HIV-1-and HTLV1/HIV1-infected rabbits . Supernatants positive for RT activity also showed moderate to high levels of HIV-1 p24 antigen as measured by an antigen capture assay (data not shown). No RT activity or p24 antigen was seen in PBL cultures or cocultures from rabbits infected with HTLV1 alone or injected with uninfected A3 .01 cells .
Confirmation that PBL were infected with HIV-1 was given by analysis of PCRamplified DNA from A3.01 cells cultured with supernatants from PBL from infected rabbits . The bands (Fig. 3 ) indicated by ethidium bromide staining were of the predicted size for the intact (574 bp) and Hind III-digested gag gene fragments (448 bp) for the isolate used here (13) and most reported HIVA sequences . Further proof that the PCR fragments are HIV I derived is given by Southern blot analysis using a probe derived from the gag region ofthe HIV-1 proviral genome (Fig. 3, right) .
Clinical Effects of HIV-I Infection. Rabbits infected with HTLV1 or HIV I alone showed no consistent signs of illness . Of the six rabbits infected with both HTLV1 and HIV 1, all had severe diarrhea and two animals suffered losses of -15 0/c body weight . Another in this group developed a rapidly progressing mammary adenocarcinoma, a rare tumor in rabbits that have never borne offspring . Two of the rabbits displayed transient (ti5 d) paralysis of the hind legs .
A rabbit infected with HIV-1 alone was killed at 8 wk post-infection . The spleen was enlarged and hyperplastic, and the lungs of this animal displayed lymphocytic mo after HIV-1 infection . Splenic hyperplasia and lymphocytic lung infiltration were diagnosed in both and moderate kidney and liver damage was seen . Coculture of the spleens with A3 .01 cells yielded RT+ supernatants . Discussion The in vivo infections described here were based on results (6) showing replication of HIV I in transformed rabbit T cell and macrophage lines but not in PBL from normal rabbits . It was reasoned from reports utilizing HTLV1 to infect rabbits (9, 15, 16) and from reported negative results using purified HIV-1 (17) that rabbits could not be infected without some manipulation to render them susceptible . Accordingly, animals were first infected with HTLV1, and then injected with a human cell line infected with HIV-1 . As shown by the present results, preinfection is not necessary to achieve infection although antibody concentrations were higher and disease symptoms more pronounced in the HTLV 1/HIV 1-infected group.
Several key questions remain concerning the infection of rabbits with HIV 1 . The most effective means of infection and of transmission are yet to be established . The precise mechanism of infection is obscure ; it is not known whether it is similar to that determined for primates . Circumstances under which disease is consistently 325 produced in this species need to be elucidated. A critical issue relates to determination of the effects of HIV-1 on immunologic status in the rabbit ; it is not known whether immune deficiency results. A complete answer to this question will require acquisition of new basic information concerning the immune system of the rabbit . There is also the possibility that predisposition to HIV-1-induced disease involves genetic factors . Recently it was shown that certain inbred rabbits are prone to leukemialike disease when exposed to HTLV1 (15, 16) whereas normal rabbits show no signs of HTLV1-induced disease .
The experiments described here, as well as those recently reported by others (7), indicate that the rabbit may serve as a model for infection with HIV-1, the causative agent in the disease AIDS. Advantages over existing models include availability of animals, relatively lower maintenance costs, and the use of HIV-1 rather than related viruses . Clearly, further information is required for a complete comprehension of the HIV-1 infection process in rabbits, but the model described here offers an immediate opportunity to investigate prophylactic and therapeutic agents directed against HIV-1 infections .
Summary
Injection ofrabbits with a human T cell line infected with HIV-1 caused seroconversion within 6 wk, and HIV-1 could be isolated from PBL cultures ofinfected rabbits. Identity of the isolated virus with HIV-1 was shown by analysis ofproducts amplified by the polymerase chain reaction . HIV-1 infection was seen in rabbits injected with HIV-1-infected cells alone as well as in those that were first infected with HTLV-1 and subsequently with HIV 1 . There were no consistent signs ofdisease in the rabbits infected with HIV-1 alone but HTLV1/HIV1-infected rabbits showed signs of illness including diarrhea and weight loss, transient neurologic impairment and, in one animal, a rapidly progressing mammary adenocarcinoma . Examination of organs taken at necropsy from both HIV-1-and HTLV1/HIV 1-infected animals showed splenic hyperplasia and lymphocyte infiltration of the lungs, as well as moderate damage to liver and kidney in some cases .
